These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 8106686)
1. Atracurium infusions in patients with fulminant hepatic failure awaiting liver transplantation. Bion JF; Bowden MI; Chow B; Honisberger L; Weatherley BC Intensive Care Med; 1993; 19 Suppl 2():S94-8. PubMed ID: 8106686 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and dynamics of atracurium infusions after paediatric orthotopic liver transplantation. Chow B; Bowden MI; Ho E; Weatherley BC; Bion JF Br J Anaesth; 2000 Dec; 85(6):850-5. PubMed ID: 11732518 [TBL] [Abstract][Full Text] [Related]
3. Clearance of atracurium and laudanosine in the urine and by continuous venovenous haemofiltration. Shearer ES; O'Sullivan EP; Hunter JM Br J Anaesth; 1991 Nov; 67(5):569-73. PubMed ID: 1751271 [TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamics and atracurium and laudanosine concentrations during a fixed continuous infusion of atracurium in mechanically ventilated patients with acute respiratory distress syndrome. Lefrant JY; Farenc C; De la Coussaye JE; Muller L; Ripart J; Cuvillon P; Saissi G; Eledjam JJ Anaesth Intensive Care; 2002 Aug; 30(4):422-7. PubMed ID: 12180578 [TBL] [Abstract][Full Text] [Related]
5. Laudanosine and atracurium concentrations in a patient receiving long-term atracurium infusion. Grigore AM; Brusco L; Kuroda M; Koorn R Crit Care Med; 1998 Jan; 26(1):180-3. PubMed ID: 9428564 [TBL] [Abstract][Full Text] [Related]
6. Plasma laudanosine levels in patients given atracurium during liver transplantation. Lawhead RG; Matsumi M; Peters KR; Landers DF; Becker GL; Earl RA Anesth Analg; 1993 Mar; 76(3):569-73. PubMed ID: 8452269 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the pharmacodynamics and pharmacokinetics of an infusion of cis-atracurium (51W89) or atracurium in critically ill patients undergoing mechanical ventilation in an intensive therapy unit. Boyd AH; Eastwood NB; Parker CJ; Hunter JM Br J Anaesth; 1996 Mar; 76(3):382-8. PubMed ID: 8785138 [TBL] [Abstract][Full Text] [Related]
8. A comparison of cisatracurium (51W89) and atracurium by infusion in critically ill patients. Newman PJ; Quinn AC; Grounds RM; Hunter JM; Boyd AH; Eastwood NB; Pollard BJ; Pearson AJ; Harper NJ; Beale RJ; Sutjarittam M; Elliot JM; Bion JF Crit Care Med; 1997 Jul; 25(7):1139-42. PubMed ID: 9233738 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and neuromuscular blocking effects of atracurium besylate and two of its metabolites in patients with normal and impaired renal function. Vandenbrom RH; Wierda JM; Agoston S Clin Pharmacokinet; 1990 Sep; 19(3):230-40. PubMed ID: 2394062 [TBL] [Abstract][Full Text] [Related]
10. Disposition of infusions of atracurium and its metabolite, laudanosine, in patients in renal and respiratory failure in an ITU. Parker CJ; Jones JE; Hunter JM Br J Anaesth; 1988 Nov; 61(5):531-40. PubMed ID: 3207525 [TBL] [Abstract][Full Text] [Related]
11. Concentrations of atracurium and laudanosine in cerebrospinal fluid and plasma in three intensive care patients. Gwinnutt CL; Eddleston JM; Edwards D; Pollard BJ Br J Anaesth; 1990 Dec; 65(6):829-32. PubMed ID: 2265055 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of atracurium and its metabolites in patients with normal renal function, and in patients in renal failure. Ward S; Boheimer N; Weatherley BC; Simmonds RJ; Dopson TA Br J Anaesth; 1987 Jun; 59(6):697-706. PubMed ID: 3606914 [TBL] [Abstract][Full Text] [Related]
14. The pharmacokinetics and pharmacodynamics of atracurium in patients with and without renal failure. Fahey MR; Rupp SM; Fisher DM; Miller RD; Sharma M; Canfell C; Castagnoli K; Hennis PJ Anesthesiology; 1984 Dec; 61(6):699-702. PubMed ID: 6239574 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic modelling of a parent drug and its metabolite. Atracurium and laudanosine. Nigrovic V; Banoub M Clin Pharmacokinet; 1992 May; 22(5):396-408. PubMed ID: 1505145 [TBL] [Abstract][Full Text] [Related]
16. Atracurium and laudanosine pharmacokinetics in acute renal failure. Hunter JM Intensive Care Med; 1993; 19 Suppl 2():S91-3. PubMed ID: 8106685 [No Abstract] [Full Text] [Related]
17. Plasma concentrations of laudanosine, but not of atracurium, are increased during the anhepatic phase of orthotopic liver transplantation in pigs. Pittet JF; Tassonyi E; Schopfer C; Morel DR; Mentha G; Fathi M; Le Coultre C; Steinig DA; Benakis A Anesthesiology; 1990 Jan; 72(1):145-52. PubMed ID: 2297117 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of atracurium and laudanosine in the elderly. Kent AP; Parker CJ; Hunter JM Br J Anaesth; 1989 Dec; 63(6):661-6. PubMed ID: 2611066 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of atracurium and laudanosine in patients with hepatic cirrhosis. Parker CJ; Hunter JM Br J Anaesth; 1989 Feb; 62(2):177-83. PubMed ID: 2923767 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and pharmacodynamics of cisatracurium in patients with end-stage liver disease undergoing liver transplantation. De Wolf AM; Freeman JA; Scott VL; Tullock W; Smith DA; Kisor DF; Kerls S; Cook DR Br J Anaesth; 1996 May; 76(5):624-8. PubMed ID: 8688259 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]